Theriva™ Biologics Announces Upcoming Presentations at Medical Meetings
Provided By GlobeNewswire
Last update: Oct 13, 2025
- VCN-01 expanded mPDAC data from VIRAGE Phase 2b trial to be presented at ESMO 2025 -
- SYN-004 Interim blinded safety and pharmacokinetic data to be presented at IDWeek 2025 -
Read more at globenewswire.com0.345
+0 (+0.88%)
Find more stocks in the Stock Screener
TOVX Latest News and Analysis
